Envista Holdings Corporation
NYSEEnvista Holdings is caught in a tug of war. JP Morgan just upgraded the dental equipment maker. At the same time, short sellers have been aggressively building positions. JP Morgan analyst Lilia-Celine Lozada upgraded NVST to Overweight on September 3. The price target rose to $32, up from $29. The stock trades at $27.59…
NVST upgraded to Overweight by JP Morgan with $32 price target, up 10% from $29; stock at $27.39 near 1-month lows despite short interest surging 47% over past month to 7.4% of float.
Snapshot as of 20 Sept 2026
Envista Holdings is caught in a tug of war. JP Morgan just upgraded the dental equipment maker. At the same time, short sellers have been aggressively building positions. JP Morgan analyst Lilia-Celine Lozada upgraded…
Envista Holdings heads into its May 19 earnings with a genuinely mixed setup: short interest that has climbed sharply over the past month, options traders leaning bullish, and the Street still split between caution and…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NVST — free to start on ORTEX.
Sign up for free →Open NVST on ORTEX